High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: Application to pharmacokinetics
References (17)
- et al.
Am. J. Cardiol.
(1980) - et al.
J. Chromatogr.
(1977) - et al.
J. Chromatogr.
(1983) - et al.
J. Pharm. Sci.
(1984) - et al.
J. Chromatogr.
(1983) - et al.
J. Pharm. Sci.
(1984) - et al.
J. Chromatogr.
(1979) - et al.
J. Chromatogr.
(1978)
There are more references available in the full text version of this article.
Cited by (71)
Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: Possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin
2011, Pharmacological ReportsCitation Excerpt :The blood samples were centrifuged (13,000 rpm, 3 min ), and a 200-µL aliquot of plasma samples was stored at –40°C until the HPLC analysis. The plasma concentrations of diltiazem were determined using a modified version of the HPLC assay reported by Goebel and Kolle [12]. Briefly, 50 µl of imipramine (2 µg/ml), as the internal standard, and 1.2 ml of tert-butylmethylether was added to 0.2 ml of the plasma sample.
Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats
2005, International Journal of PharmaceuticsPharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats
2005, Pharmacological ResearchEnhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits
2005, International Journal of PharmaceuticsHigh-performance liquid chromatography-mass spectrometry analysis of diltiazem and 11 of its phase I metabolites in human plasma
2003, Journal of Pharmaceutical and Biomedical AnalysisUnderstanding the hysteresis loop conundrum in pharmacokinetic / pharmacodynamic relationships
2014, Journal of Pharmacy and Pharmaceutical Sciences
Copyright © 1985 Published by Elsevier B.V.